STOCK TITAN

RYTM (NASDAQ: RYTM) brokered notice for 35,460-share sale on 03/03/2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RYTM proposed sale of 35,460 common shares on 03/03/2026. The filing lists 35,460 shares tied to an exercise of options under a registered plan and an aggregate value of $3,209,778.92 on 03/03/2026. The transaction is reported through Morgan Stanley Smith Barney LLC on NASDAQ.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 sale notice tied to option exercise; limited immediate market impact.

The filing lists 35,460 shares proposed for sale following an exercise of options under a registered plan on 03/03/2026 with an aggregate value of $3,209,778.92. This is a notification of intent to sell under Rule 144 rather than an executed open‑market transaction.

Price and execution timing are not provided; market impact depends on how and when the shares are sold and on existing float. Subsequent transaction reports or broker disclosures will specify execution details.

Sale originates from option exercise under a registered plan; administrative disclosure.

The entry names Morgan Stanley Smith Barney LLC as the broker for the proposed sale of 35,460 shares on 03/03/2026. The method cites an exercise of options under a registered plan, indicating shares became available through a plan process.

Share disposition mechanics and any beneficial‑ownership changes are not shown here; further SEC reports may confirm final sale amounts and any resulting ownership changes.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RYTM's Form 144 disclose?

The Form 144 shows a proposed sale of 35,460 common shares tied to an exercise of options under a registered plan with aggregate value $3,209,778.92 on 03/03/2026.

Who is listed as the broker in the RYTM filing?

The filing lists Morgan Stanley Smith Barney LLC as the broker handling the proposed sale of 35,460 shares on 03/03/2026, executed on NASDAQ.

Does the Form 144 confirm the shares were sold?

No. The Form 144 notifies intent to sell 35,460 shares; it does not confirm execution. Final sale details would appear in subsequent transaction reports.

How large is the proposed sale in dollar terms?

The filing cites an aggregate value of $3,209,778.92 for the 35,460 shares proposed for sale on 03/03/2026.

What method allowed these shares to be sold?

The shares are associated with an exercise of options under a registered plan, indicating they became available through plan exercise before the proposed resale on 03/03/2026.
Rhythm Pharmaceu

NASDAQ:RYTM

View RYTM Stock Overview

RYTM Rankings

RYTM Latest News

RYTM Latest SEC Filings

RYTM Stock Data

6.39B
63.38M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON